BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6314075)

  • 1. Opioid antinociception and positive reinforcement are mediated by different types of opioid receptors.
    Pollerberg GE; Costa T; Shearman GT; Herz A; Reid LD
    Life Sci; 1983 Oct; 33(16):1549-59. PubMed ID: 6314075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrical stimulation at traditional acupuncture sites in periphery produces brain opioid-receptor-mediated antinociception in rats.
    Chen XH; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1996 May; 277(2):654-60. PubMed ID: 8627542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid receptor subtypes associated with ventral tegmental facilitation and periaqueductal gray inhibition of feeding.
    Jenck F; Quirion R; Wise RA
    Brain Res; 1987 Oct; 423(1-2):39-44. PubMed ID: 2823993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone and diprenorphine reduce responding for brain self-stimulation in a fixed-ratio schedule in rats.
    Schaefer GJ; Michael RP
    Pharmacol Biochem Behav; 1988 Jan; 29(1):209-12. PubMed ID: 3353428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing fentanyl antinociception and preventing tolerance with α-2 adrenoceptor agonists in rats.
    Yildiz Pehlivan D; Kara AY; Koyu A; Simsek F
    Behav Brain Res; 2024 Feb; 457():114726. PubMed ID: 37865211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine and diprenorphine together potentiate intake of alcoholic beverages.
    Reid LD; Czirr SA; Bensinger CC; Hubbell CL; Volanth AJ
    Alcohol; 1987; 4(3):161-8. PubMed ID: 3036177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid receptor subtypes associated with ventral tegmental facilitation of lateral hypothalamic brain stimulation reward.
    Jenck F; Gratton A; Wise RA
    Brain Res; 1987 Oct; 423(1-2):34-8. PubMed ID: 2823990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different mechanisms mediate beta-endorphin- and morphine-induced inhibition of the tail-flick response in rats.
    Tseng LF; Tang R
    J Pharmacol Exp Ther; 1990 Feb; 252(2):546-51. PubMed ID: 2156050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for opioid and non-opioid forms of stimulation-produced analgesia in the rat.
    Cannon JT; Prieto GJ; Lee A; Liebeskind JC
    Brain Res; 1982 Jul; 243(2):315-21. PubMed ID: 7104742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa-receptor antagonist reverse 'non-opioid' stress-induced analgesia.
    Panerai AE; Martini A; Sacerdote P; Mantegazza P
    Brain Res; 1984 Jun; 304(1):153-6. PubMed ID: 6331578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive actions of intrathecal xylazine: interactions with spinal cord opioid pathways.
    Goodchild CS; Guo Z; Davies A; Gent JP
    Br J Anaesth; 1996 Apr; 76(4):544-51. PubMed ID: 8652328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addictive agents and intracranial stimulation (ICS): novel antagonists and agonists of morphine and pressing for ICS.
    Bermudez-Rattoni F; Cruz-Morales S; Reid LD
    Pharmacol Biochem Behav; 1983 May; 18(5):777-84. PubMed ID: 6856650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diprenorphine and naloxone in squirrel monkeys with enhanced sensitivity to opioid antagonists.
    Oliveto AH; Dykstra LA
    Psychopharmacology (Berl); 1988; 95(3):339-43. PubMed ID: 3137619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine analgesia and acute physical dependence: rapid onset of two opposing, dose-related processes.
    Kim DH; Fields HL; Barbaro NM
    Brain Res; 1990 May; 516(1):37-40. PubMed ID: 2163724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive effects of stimulation of discrete sites in the rat hypothalamus: evidence for the participation of the lateral hypothalamus area in descending pain suppression mechanisms.
    Franco AC; Prado WA
    Braz J Med Biol Res; 1996 Nov; 29(11):1531-41. PubMed ID: 9196558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of naloxone and diprenorphine on spontaneous activity in rats and mice.
    DeRossett SE; Holtzman SG
    Pharmacol Biochem Behav; 1982 Aug; 17(2):347-51. PubMed ID: 7134243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone-reversible analgesia induced by electrical stimulation of the habenula in the rat.
    Mahieux G; Benabid AL
    Brain Res; 1987 Mar; 406(1-2):118-29. PubMed ID: 3032353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
    Adams JU; Paronis CA; Holtzman SG
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1027-32. PubMed ID: 2175793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal antinociception by Tyr-D-Ser(otbu)-Gly-Phe-Leu-Thr, a selective delta-opioid receptor agonist.
    Kalso EA; Sullivan AF; McQuay HJ; Dickenson AH
    Eur J Pharmacol; 1992 May; 216(1):97-101. PubMed ID: 1326441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone-induced analgesia in diabetic mice.
    Kamei J; Kawashima N; Kasuya Y
    Eur J Pharmacol; 1992 Jan; 210(3):339-41. PubMed ID: 1319338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.